10x Genomics Inc.

NASDAQ: TXG · Real-Time Price · USD
13.63
0.39 (2.95%)
At close: Aug 15, 2025, 9:46 AM

10x Genomics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-182.63M -255.1M -166M -58.22M
Depreciation & Amortization
43.71M 43.62M 33.01M 28.25M
Stock-Based Compensation
140.75M 166.95M 136.85M 95.96M
Other Working Capital
-12.57M 26.1M -5.13M -34.36M
Other Non-Cash Items
3.58M 11.99M 1.96M 79K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
1.25M 17.34M -39.42M -87.44M
Operating Cash Flow
6.66M -15.2M -33.61M -21.37M
Capital Expenditures
-12.39M -49.52M -131.66M -101.28M
Cash Acquisitions
n/a n/a -4M -5.45M
Purchase of Investments
-48.88M n/a -282.87M n/a
Sales Maturities Of Investments
29.64M 183.02M 67.64M n/a
Other Investing Acitivies
-1M -923K n/a n/a
Investing Cash Flow
-32.63M 133.49M -350.89M -106.73M
Debt Repayment
n/a -5.81M -5.41M -5.03M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a
Financial Cash Flow
10.91M 13.67M 15.82M 35.3M
Net Cash Flow
-15.22M 131.93M -368.72M -92.57M
Free Cash Flow
-5.73M -64.72M -165.27M -122.65M